International Journal of Infection

Published by: Kowsar

Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever

Seyed Mohammad Hashemi-Shahri 1 , Batool Sharifi-Mood 1 , * and Maliheh Metanat 1
Authors Information
1 Infectious Diseases and Tropical Medicine Research Center, Zahedan University of Medical Sciences, Zahedan, IR Iran
Article information
  • International Journal of Infection: September 20, 2014, 1 (3); e21519
  • Published Online: September 10, 2014
  • Article Type: Research Article
  • Received: April 10, 2014
  • Revised: June 29, 2014
  • Accepted: July 20, 2014
  • DOI: 10.17795/iji-21519

To Cite: Hashemi-Shahri S M, Sharifi-Mood B, Metanat M. Risk Factors Associated With Poor Prognosis in Children With Crimean-Congo Hemorrhagic Fever, Int J Infect. 2014 ; 1(3):e21519. doi: 10.17795/iji-21519.

Copyright © 2014, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. W.H.O. . Crimean-Congo haemorrhagic fever (CCHF). World Health Organization 2014;
  • 2. Chinikar S, Ghiasi SM, Moradi M, Goya MM, Shirzadi MR, Zeinali M, et al. Geographical distribution and surveillance of Crimean-Congo hemorrhagic fever in Iran. Vector Borne Zoonotic Dis. 2010; 10(7): 705-8[DOI][PubMed]
  • 3. Metanat M, Sharifi-Mood B, Tabatabaei M, Shirazi MS. Can Serum Ferritin Level Predict Disease Severity in Patients with Crimean-Congo Hemorrhagic Fever? Eurasian J Med. 2013; 48: 108-14
  • 4. Mardani M, Keshtkar-Jahromi M. Crimean-Congo hemorrhagic fever. Arch Iran Med. 2007; 10(2): 204-14[PubMed]
  • 5. Alavi-Naini R, Moghtaderi A, Koohpayeh HR, Sharifi-Mood B, Naderi M, Metanat M, et al. Crimean-Congo hemorrhagic fever in Southeast of Iran. J Infect. 2006; 52(5): 378-82[DOI][PubMed]
  • 6. Sharifi-Mood B, Mardani M, Keshtkar-Jahromi M, Rahnavardi M, Hatami H, Metanat M. Clinical and epidemiologic features of Crimean-Congo hemorrhagic fever among children and adolescents from southeastern Iran. Pediatr Infect Dis J. 2008; 27(6): 561-3[DOI][PubMed]
  • 7. Sharifi-Mood B, Metanat M, Ghorbani-Vaghei A, Fayyaz-Jahani F, Akrami E. The outcome of patients with Crimean-Congo hemorrhagic fever in Zahedan, southeast of Iran: a comparative study. Arch Iran Med. 2009; 12(2): 151-3[PubMed]
  • 8. Mardani M, Keshtkar-Jahromi M, Ataie B, Adibi P. Crimean-Congo hemorrhagic fever virus as a nosocomial pathogen in Iran. Am J Trop Med Hyg. 2009; 81(4): 675-8[DOI][PubMed]
  • 9. Mardani M, Poorkaveh B. Crimean-Congo Hemorrhagic Fever. Iran J Clin Infect Dis. 2012; 7(1): 36-9
  • 10. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: severity criteria revisited. Clin Microbiol Infect. 2006; 12(6): 551-4[DOI][PubMed]
  • 11. Brug J, Aro AR, Oenema A, de Zwart O, Richardus JH, Bishop GD. SARS risk perception, knowledge, precautions, and information sources, the Netherlands. Emerg Infect Dis. 2004; 10(8): 1486-9[DOI][PubMed]
  • 12. Oflaz MB, Bolat F, Kaya A, Guven AS, Kucukdurmaz Z, Karapinar H, et al. Resting heart rate in children with Crimean-Congo hemorrhagic fever: a tool to identify patients at risk? Vector Borne Zoonotic Dis. 2014; 14(1): 59-65[DOI][PubMed]
  • 13. Tasdelen Fisgin N, Tanyel E, Doganci L, Tulek N. Risk factors for fatality in patients with Crimean-Congo haemorrhagic fever. Trop Doct. 2009; 39(3): 158-60[DOI][PubMed]
  • 14. Tabatabaei SM, Hassanzehi A, Pakzad A, Mohammadi M, Madani M. Factors Influencing Crimean-Congo Hemorrhagic Fever Risk Perceptions in the General Population, Southeast Iran. Int J Infection. 2014; 1(1)
  • 15. Chinikar S, Mazaheri V, Mirahmadi R, Nabeth P, Francoise-Saron M, Salehi P. Serological survey in suspected human patients of CCHF in Iran by determination of IgM-ELISA method during 2000–2004. Arch Iran Med. 2006; 8: 52-5
  • 16. Mardani M, Keshtkar JM, Holakoi N, Zinali M. The efficacy of oral ribavirin in the treatment of 81 proved cases of Crimean-Congo hemorrhagic fever in Iran (1991–2001). Med J I R Iran. 2003; 3: 193-5
  • 17. Metanat M, Sharifi-Mood B, Salehi M, Alavi-Naini R. Clinical outcomes in Crimean-Congo hemorrhagic fever: A five-years experience in the treatment of patients in oral Ribavirin. Int J Virol. 2006; 2: 21-4
  • 18. Sharifi Mood B, Alavi-Naini R, Metanat M, Rakhshani F. Ribavirin: an effective drug for treatment of children with Crimean Congo hemorrhagic fever: a seven years experience. Pak J Biolo Sci. 2006; 9: 1598-600
  • 19. Rakhshani M, Abedi-poou F, Noori-Jangi M, Khorgami P, Hajalizadeh A. A five-member family with Crimean-Congohemorrhagic fever;A case series study. Int J infection. 2014; 1(1)
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments